<DOC>
	<DOCNO>NCT02211300</DOCNO>
	<brief_summary>The objective study demonstrate OptiScanner® safe provide accurate blood glucose level critically ill subject . Accuracy Hypothesis : The assessment blood glucose level result OptiScanner comparable YSI 2300 STAT Plus™ Glucose Lactate Analyzer ( `` YSI Analyzer '' ; YSI Life Sciences , Yellow Springs , OH ) . Safety Hypothesis : The OptiScanner acceptable risk/benefit profile system provide repeat automated blood glucose level critically ill subject .</brief_summary>
	<brief_title>MANAGE Automated Glucose Monitoring</brief_title>
	<detailed_description />
	<criteria>Signed informed consent participant his/her legally authorize representative At least 18 year old Admitted ICU CCU Expected ICU CCU stay least 18 hour time enrollment ( judged Investigator ) Requires blood glucose monitoring ; A vascular access device dedicate connection OptiScanner either already inplace , plan place another purpose , opinion Investigator safely place exclusively use study , another access device place place manually draw sample evaluate use YSI Analyzer . Note CVCs place solely purpose conduct study . Refer section 1.2.7 detail regard vascular access device guideline selection placement . Pregnant nursing In Investigator 's opinion subject safely tolerate amount saline require give subject ( 360 mL per day ) Hematocrit le 15 % great 60 % Subjects require placement additional vascular access line exclude suitable access site free follow condition : Peripheral vascular disease History placement site neuropathy chronic pain History placement extremity coagulopathy clot formation History vascular surgery extremity catheter placement Any medical condition , Investigator 's opinion , would warrant exclusion study prevent subject completing study , include limited high risk complication associate vascular access ; Participation investigational drug device study last 30 day and/or enrol study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>glucose monitoring</keyword>
	<keyword>OptiScanner</keyword>
</DOC>